ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 896

Tyro3, Axl, MerTK-Receptor Activation by Gas6 or Pros1 Gene Delivery, ameliorates Collagen-induced arthritis

Fons A.J. van de Loo1, Ben T. van Den Brand2, Shahla Abdollahi-Roodsaz3, Eline A. Vermeij4, Miranda B. Bennink4, Onno J. Arntz5 and Wim B. van den Berg6, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 5Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Nijmegen, Netherlands, 6Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines and synovitis, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Insufficient controlled activation of innate immunity by cytokines and pattern recognition receptors could develop into auto-immune diseases. Stimulation of  dendritic cells via the Axl receptor in conjunction with IFNAR leads to upregulation of suppressor of cytokine signaling (SOCS) proteins 1 and 3 and broadly inhibit both Toll-like Receptor (TLR) signaling and TLR-induced cytokine-receptor cascades (Rothlin et al. Cell 2007). This study evaluated whether Tyro3 Axl MerTK (TAM)- receptor stimulation by Growth arrest specific 6 (Gas6) and Protein S (Pros1) as natural negative feedback for Toll-Like Receptor and cytokine signaling can be used to treat collagen-induced arthritis.

Methods:

Adenoviruses (1x10E7 FFU) overexpressing Gas6 and Pros1 were injected intravenously (i.v.) or 3x10E8 FFU intra-articularly (i.a.) into mice before onset of collagen-induced arthritis. Splenic T-helper subsets of intravenously injected were studied by flow cytometry and knee joints of mice injected i.v. and i.a. were assessed histologically. Messenger RNA expression was analyzed in synovium of i.a. injected mice. Ciruclating cytokines were measured on a Luminex-100 System (Luminex corp.) using a magnetic bead-based multiplex immunoassay (Milliplex, Merck Millipore). Joint inflammation was imaged using the ProSense probe with the IVIS Lumina (Caliper Life Sciences), using the Cy5.5 filter.

Results:

Gas6 or Pros1 did not affect arthritis incidence in either IV or IA injected animals. However, Pros1 did significantly reduce ankle joint swelling, and circulating levels of KC and IL-6. Histological analysis of knee joints revealed a moderate reduction of joint pathology and a significant reduction of splenic T-helper 1 cells when Pros1 was overexpressed systemically. Local overexpression of Gas6 decreased joint inflammation (as assessd histologically or imaged by ProSense) and joint pathology. Pros1 treatment showed a similar trend of protection. Consistently, Gas6 and Pros1 markedly reduced cytokine (IL-1β, IL-6, and TNFα) production in synovium. Moreover, IL-12 and IL-23 mRNA levels were reduced by Gas6 and Pros1, corresponding to a decrease in IFNγ and IL-17 production in synovium.

Conclusion:

We provide the first evidence that TAM receptor stimulation by Gas6 and Pros1 can be used to ameliorate arthritis when applied systemically or locally. TAM receptor stimulation limits proinflammatory signaling and the adaptive immunity. This pathway provides a novel strategy to combat rheumatoid arthritis.


Disclosure:

F. A. J. van de Loo,
None;

B. T. van Den Brand,
None;

S. Abdollahi-Roodsaz,
None;

E. A. Vermeij,
None;

M. B. Bennink,
None;

O. J. Arntz,
None;

W. B. van den Berg,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tyro3-axl-mertk-receptor-activation-by-gas6-or-pros1-gene-delivery-ameliorates-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology